Richard Quigg to Complement C5a
This is a "connection" page, showing publications Richard Quigg has written about Complement C5a.
Connection Strength
1.358
-
C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol. 2005 Aug; 35(8):2496-506.
Score: 0.268
-
Absence of complement factor H reduces physical performance in C57BL6 mice. Immunobiology. 2020 09; 225(5):152003.
Score: 0.191
-
C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology. 2016 08; 148(4):407-19.
Score: 0.143
-
C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology. 2015 Sep; 146(1):130-43.
Score: 0.134
-
Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor. Cell Mol Immunol. 2016 09; 13(5):651-7.
Score: 0.134
-
Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells. Immunology. 2014 Nov; 143(3):363-73.
Score: 0.127
-
C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-?B. J Neurochem. 2011 Dec; 119(5):1041-51.
Score: 0.103
-
Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol. 2010 Apr 15; 221(1-2):46-52.
Score: 0.092
-
C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010 Jun; 24(6):1682-8.
Score: 0.091
-
Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis. Lab Invest. 2007 Apr; 87(4):357-64.
Score: 0.074